
Atrial Fibrillation
Antithrombotic Therapy in patients with Acute Coronary Syndromes
Elderly patients with Heart Disease
Biomarkers in Acute Coronary Syndromes and Atrial Fibrillation
Thrombosis and Anticoagulation and novel antithrombotic agents
Metabolomics in Cardiovascular Medicine
Education and Training
- M.H.S., Duke University School of Medicine, 2009
- Ph.D., Paulista Medical School, University of Sao Paulo (Brazil), 2006
- M.D., University of Santo Amaro (Brazil), 2001
Grants
- Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation
- PRA-Ionis ATTR-CM
- Bayer-20115-CONVERT
- Bayer-21170-RE-THINc
- H9X-MC-GBGO
- AF Detection, Diagnosis and Drug Therapy EDucational Program (AF-4Ds)
- Integrated Biostatistical Training for CVD Research
- Trial to Assess Chelation Therapy 2 (TACT2) Data Coordinating Center
- Sanofi SOTA Outcomes EFC15156